- Home
- OPTT vs CYCN Comparison
OPTT vs CYCN Comparison
Compare OPTT & CYCN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OPTT | CYCN |
|---|---|---|
| Founded | 1984 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 7.6M |
| IPO Year | 2007 | N/A |
Fundamental Metrics
Financial Performance| Metric | OPTT | CYCN |
|---|---|---|
| Price | $0.35 | $1.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $1.50 | N/A |
| AVG Volume (30 Days) | ★ 3.8M | 46.2K |
| Earning Date | 12-15-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,748,000.00 | $2,855,000.00 |
| Revenue This Year | $94.90 | N/A |
| Revenue Next Year | $74.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 1371.65 |
| 52 Week Low | $0.29 | $1.28 |
| 52 Week High | $1.75 | $6.25 |
Technical Indicators
Market Signals| Indicator | OPTT | CYCN |
|---|---|---|
| Relative Strength Index (RSI) | 40.65 | 40.67 |
| Support Level | $0.30 | $1.43 |
| Resistance Level | $0.46 | $1.64 |
| Average True Range (ATR) | 0.03 | 0.12 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 33.61 | 14.63 |
Price Performance
Historical ComparisonAbout OPTT Ocean Power Technologies Inc.
Ocean Power Technologies Inc provides intelligent maritime solutions and services that enable safer, cleaner, and more productive ocean operations for the defense and security, oil and gas, science and research, and offshore wind markets. It provides ocean data collection and reporting, marine power, offshore communications, and Maritime Domain Awareness System (MDAS) products, integrated solutions, and consulting services. The company offers its products and services to a wide range of customers, including those in government and offshore energy, oil and gas, construction, wind power, and other industries. The company has operations in North and South America, Europe, Asia and Australia.
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.